BetterLife Pharma Inc.
BETRF · OTCMCIK 1464165fmd_1YBBTZWTS01T1MK7YJ5KY5JMA5Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Feb 01, 2008 to Jan 31, 2025, 45 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| Research and development | – | – | – | 0 | – | – | – | – | 0 |
| Total operating expenses | – | – | – | – | – | 0 | 10 | 6 | 1 |
| Operating income | – | – | – | – | – | (0) | (10) | (6) | (1) |
| Interest expense | – | – | – | (0) | (0) | 0 | – | 0 | 0 |
| Other non-operating income (expense) | – | – | (3) | 2 | 0 | – | – | – | – |
| Net income from continuing operations | – | – | (0) | (0) | (0) | – | – | – | – |
| Net income | (1) | (0) | (3) | 1 | 0 | (1) | (10) | (6) | (0) |
| Net income to common shareholders | – | – | (0) | 0 | 0 | – | – | – | – |